Efficacy and Safety of 5% Minoxidil Foam in Female Androgenetic Alopecia — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Efficacy and Safety of 5% Minoxidil Foam in Female Androgenetic Alopecia — Stella

Home/Androgenetic Alopecia/

View on ClinicalTrials.gov

Recruiting

Back to Androgenetic Alopecia trials

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(1 site)

China

Beijing, China, Beijing

Key details

Phase

Large-scale testing

Sponsor

Zhejiang Sunshine Mandi Pharmaceutical Co.,Ltd.

Enrollment target

~294 participants

Started

February 2025

Primary completion

December 2027

Age range

18 Years and older

Sex

Female only

Last updated March 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.